Total Funding
59
58
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
55623
NeuroNOS is a company focused on developing innovative treatments for Autism Spectrum Disorder (ASD) and other neurological conditions.
Amir Avniel: CEOPast Role: Beyond Air, President & COO- Haitham Amal: CSO & Co-Founder
About the Company
NeuroNOS is a biopharmaceutical company dedicated to developing innovative treatments for Autism Spectrum Disorder (ASD) and other neurological conditions. The company focuses on regulating nitric oxide (NO) levels in the brain, aiming to address the biological mechanisms underlying ASD and improve cognitive and behavioral functions.
